3-tyr-octreotide has been researched along with Hormone-Dependent Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Angelberger, P; Luger, A; Neuhold, N; Pantev, T; Sinzinger, H; Virgolini, I | 1 |
| Besser, GM; Bomanji, J; Britton, KE; Grossman, AB; Mather, SJ; Ur, E; Wass, JA | 1 |
2 other study(ies) available for 3-tyr-octreotide and Hormone-Dependent Neoplasms
| Article | Year |
|---|---|
Evaluation of somatostatin receptors in human cancer.
Topics: Adenoma; Binding, Competitive; Biomarkers, Tumor; Humans; Neoplasms, Hormone-Dependent; Octreotide; Pituitary Neoplasms; Radioligand Assay; Receptors, Neurotransmitter; Receptors, Somatostatin; Tomography, Emission-Computed, Single-Photon; Tumor Cells, Cultured | 1991 |
Localization of neuroendocrine tumours and insulinomas using radiolabelled somatostatin analogues, 123I-Tyr3-octreotide and 111In-pentatreotide.
Topics: Adult; Aged; Evaluation Studies as Topic; Female; Humans; Indium Radioisotopes; Insulinoma; Iodine Radioisotopes; Male; Middle Aged; Neoplasms, Hormone-Dependent; Octreotide; Pentetic Acid; Somatostatin; Tomography, Emission-Computed, Single-Photon | 1993 |